Richard Paul Strommer
Known title: Chief ActuaryCIK: 0001963517
Associated companies
Transaction History
| GLRE | ▼ Sell | Open Market | 2,786 | $0 | 3/9/2026 | View on chart |
| GLRE | ▲ Buy | Grant | 4,388 | $0 | 3/14/2025 | View on chart |
| GLRE | ▲ Buy | Grant | 4,623 | $0 | 3/13/2025 | View on chart |
| GLRE | ▼ Sell | Open Market | 4,139 | $0 | 3/10/2025 | View on chart |
| GLRE | ▲ Buy | Grant | 3,881 | $0 | 3/15/2024 | View on chart |
| GLRE | ▲ Buy | Grant | 21,193 | $0 | 3/15/2023 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
Greenlight Capital Q2 Letter and Valuation Analysis
Greenlight Capital released its Q2 2026 letter, outlining recent performance and strategy. A SeekingAlpha piece notes the company’s book value is 0.7x, suggesting a low valuation until ROE is examined. These reports give a clearer view of the firm’s fundamentals and potential upside.
Greenlight Capital Q2 Letter and Valuation Analysis. Greenlight Capital released its Q2 2026 letter, outlining recent performance and strategy. A SeekingAlpha piece notes the company’s book value is 0.7x, suggesting a low valuation until ROE is examined. These reports give a clearer view of the firm’s fundamentals and potential upside.